Research & Clinical Trials

Parkinson’s Clinical Trial Listings: Read Phase, Location, and Eligibility

Learn how to check a Parkinson's trial's phase, local enrollment status, and screening requirements.

How to Read a Parkinson’s Breakthrough Headline

Most Parkinson's “breakthrough” headlines describe a result in mice, a trial of forty people, or a company press release. None of those are worthless,...

Parkinson’s Research: What Current Evidence Actually Supports

See which Parkinson's treatments help now, which approaches fell short, and what emerging research can—and cannot—show.

Parkinson’s Disease News: What Current Evidence Actually Supports

Learn which Parkinson's advances are available now, which remain experimental, and what trial results mean for daily care.

Early Signs of Parkinson’s Research Review: Findings, Gaps, and Practical Context

Learn which early Parkinson's signs merit evaluation, what biomarkers reveal, and where prediction still falls short.

Personalized stem cell treatment for Parkinson’s: New research shows promising clinical results

See what 12-month trial data reveal about personalized stem cell therapy for Parkinson's—and the limits behind the promising numbers.

SB-0110 Shows Promise in Parkinson’s Research With Innovative PKA Targeting Approach

A clear look at SB-0110's animal results, how it targets PKA-II, and why patients still face a years-long wait.

Parkinson’s Treatment Search Guide: Questions People Are Asking and Clear Answers

People newly diagnosed with Parkinson's ask about cures, medication options, and which approaches actually work—here's what the evidence and clinical experience show.

Traffic Noise May Increase Parkinson’s Disease Risk, New Study Suggests

A major Danish cohort links long-term road noise with a small rise in Parkinson's risk and highlights the value of a quiet-side bedroom.

Personalized stem cell treatment for Parkinson’s: New research shows promising clinical results

Personalized stem cell therapies for Parkinson's show measurable clinical improvements in early trials, but remain experimental and inaccessible to most patients.

SB-0110 Shows Promise in Parkinson’s Research With Innovative PKA Targeting Approach

Researchers are exploring whether blocking a specific cellular protein called PKA could slow Parkinson's disease progression, representing a shift toward disease-modifying therapies.

Alzheimer’s and Parkinson’s research gets $5M boost from major foundations

Foundation funding accelerates discovery timelines and attracts researchers to neurodegenerative disease, though breakthroughs typically take years to reach patients.

Customized Stem Cell Regeneration Therapy Shows Promising Results for Parkinson’s Disease

Stem cell therapies aim to repair Parkinson's damage by generating replacement dopamine neurons, with early research showing encouraging but limited results.

Supine Hypertension Linked to Parkinson’s Orthostatic Hypotension: Clinical Connection

Parkinson's disease can cause a dangerous blood pressure paradox: high pressure while lying down and dangerously low pressure when standing.

Parkinson’s Research Trials: Disease Modification Now Outpaces Symptom Relief Approach

Disease-modifying therapies now drive Parkinson's research, targeting neurodegeneration itself rather than just managing movement symptoms.

Parkinson’s Stem Cell Therapy Trial Completes Patient Recruitment Phase Successfully

A major stem cell therapy trial for Parkinson's disease has finished enrolling participants, marking a critical milestone in experimental treatment research.

Six million dollar grant accelerates Parkinson’s diagnosis methods research initiative

A $6 million grant to Banner Sun Health accelerates the development of blood tests that could identify Parkinson's disease earlier than current clinical methods.

Phase 1b/2a trial enrollment complete for Parkinson’s experimental treatment RNDP-001

Phase 1b/2a trial enrollment completion signals progress in evaluating RNDP-001, but approval remains years away.

Gut microbiome dysfunction emerges as key Parkinson’s disease research focus

Scientists are investigating whether restoring healthy gut bacteria could slow or prevent Parkinson's disease.

Parkinson’s Clinical Trials Begin After FDA Approval for Developer 2026

FDA approval of new delivery methods and dozens of emerging Parkinson's therapies in clinical trials are reshaping treatment options in 2026.

1 2 Next »

We use cookies to run this site, measure how it’s used, and show ads. Choose “Essentials only” to limit cookies to what the site needs to work. Privacy Policy.